• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过 QESD 结晶改善盐酸二甲双胍的流动性并减少储存结块。

Improving flowability and reducing storage agglomeration of metformin hydrochloride through QESD crystallization.

机构信息

Heinrich-Heine-Universitaet Duesseldorf, Institute of Pharmaceutics and Biopharmaceutics, Universitaetsstraße 1, 40225 Duesseldorf, Germany.

Heinrich-Heine-Universitaet Duesseldorf, Institute of Pharmaceutics and Biopharmaceutics, Universitaetsstraße 1, 40225 Duesseldorf, Germany.

出版信息

Eur J Pharm Biopharm. 2021 Feb;159:170-176. doi: 10.1016/j.ejpb.2021.01.004. Epub 2021 Jan 15.

DOI:10.1016/j.ejpb.2021.01.004
PMID:33460735
Abstract

Metformin hydrochloride is a drug used in the treatment of type 2 diabetes and is administered orally using high-dose tablets. Due to its poor flowability and agglomeration during storage, metformin is commonly processed using an intermediate step such as granulation before the material can be compressed into tablets. Spherical crystallization is a method, which can be used to improve the flowability and tabletability of drugs and excipients. This study set out to create a simple quasi-emulsion solvent-diffusion crystallization method for the highly water-soluble metformin hydrochloride using a single solvent and antisolvent with surfactants so that a direct compression of the material can be realized. Hollow, spherical agglomerates of metformin with good flowability and reduced storage agglomeration were successfully produced using this method. The effect of different surfactants (HPMC, polysorbate 80 and sorbitane monooleate) used to stabilize the transient emulsion during crystallization as well as different system parameters on the morphology, flowability of the particles and storage agglomeration was analyzed.

摘要

盐酸二甲双胍是一种用于治疗 2 型糖尿病的药物,以高剂量片剂的形式口服给药。由于其在储存过程中流动性差且易于结块,因此在将其压缩成片剂之前,通常需要经过造粒等中间步骤进行处理。球形结晶是一种可以改善药物和赋形剂流动性和可压性的方法。本研究旨在开发一种简单的准乳液溶剂扩散结晶方法,使用单一溶剂和含有表面活性剂的反溶剂来高度水溶性的盐酸二甲双胍,从而可以直接对该物质进行压缩。使用该方法成功制备出具有良好流动性和减少储存结块的空心、球形盐酸二甲双胍团聚体。分析了在结晶过程中用于稳定瞬时乳液的不同表面活性剂(HPMC、聚山梨酯 80 和山梨坦单油酸酯)以及不同系统参数对颗粒形态、流动性和储存结块的影响。

相似文献

1
Improving flowability and reducing storage agglomeration of metformin hydrochloride through QESD crystallization.通过 QESD 结晶改善盐酸二甲双胍的流动性并减少储存结块。
Eur J Pharm Biopharm. 2021 Feb;159:170-176. doi: 10.1016/j.ejpb.2021.01.004. Epub 2021 Jan 15.
2
Enabling the direct compression of metformin hydrochloride through QESD crystallization.通过 QESD 结晶使盐酸二甲双胍能够直接压缩。
Int J Pharm. 2021 Aug 10;605:120796. doi: 10.1016/j.ijpharm.2021.120796. Epub 2021 Jun 11.
3
Enhancing flowability of lamivudine through quasi-emulsion solvent-diffusion (QESD) crystallization: A comprehensive study on surfactant impact, particle morphology by QbD concepts and tablet compression challenges.通过准乳液溶剂扩散(QESD)结晶提高拉米夫定的流动性:表面活性剂影响、QbD 概念下的颗粒形态以及片剂压缩挑战的综合研究。
Eur J Pharm Sci. 2024 Sep 1;200:106835. doi: 10.1016/j.ejps.2024.106835. Epub 2024 Jun 20.
4
Towards a better understanding of the role of stabilizers in QESD crystallizations.为了更好地理解稳定剂在QESD结晶过程中的作用。
Pharm Res. 2022 Dec;39(12):3123-3136. doi: 10.1007/s11095-022-03212-2. Epub 2022 Mar 9.
5
Microstructures and pharmaceutical properties of ferulic acid agglomerates prepared by different spherical crystallization methods.不同球形结晶方法制备阿魏酸聚集物的微观结构和药物性能。
Int J Pharm. 2020 Jan 25;574:118914. doi: 10.1016/j.ijpharm.2019.118914. Epub 2019 Dec 4.
6
Direct Compression Tablet Containing 99% Active Ingredient-A Tale of Spherical Crystallization.含 99%活性成分的直接压片-球形结晶的故事。
J Pharm Sci. 2019 Apr;108(4):1396-1400. doi: 10.1016/j.xphs.2018.11.015. Epub 2018 Nov 15.
7
Spherical agglomeration to improve dissolution and micromeritic properties of an anticancer drug, Bicalutamide.球形团聚改善抗癌药物比卡鲁胺的溶解和微粉学性质。
Drug Dev Ind Pharm. 2019 Jun;45(6):968-980. doi: 10.1080/03639045.2019.1585447. Epub 2019 Mar 7.
8
Reduction of Punch-Sticking Propensity of Celecoxib by Spherical Crystallization via Polymer Assisted Quasi-Emulsion Solvent Diffusion.球形结晶通过聚合物辅助准乳液溶剂扩散降低塞来昔布的冲压倾向。
Mol Pharm. 2020 Apr 6;17(4):1387-1396. doi: 10.1021/acs.molpharmaceut.0c00086. Epub 2020 Mar 24.
9
Spherical crystallization of drugs.药物的球晶化。
Acta Pharm. 2012 Mar;62(1):1-14. doi: 10.2478/v10007-012-0010-5.
10
Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.通过结晶共附聚技术制备用于直接压片的萘普生-崩解剂附聚物的颗粒设计
Int J Pharm. 2008 Mar 3;351(1-2):45-54. doi: 10.1016/j.ijpharm.2007.09.033. Epub 2007 Sep 29.

引用本文的文献

1
Material extrusion 3D-printing technology: A new strategy for constructing water-soluble, high-dose, sustained-release drug formulations.材料挤出3D打印技术:构建水溶性、高剂量、缓释药物制剂的新策略。
Mater Today Bio. 2024 Jul 14;27:101153. doi: 10.1016/j.mtbio.2024.101153. eCollection 2024 Aug.
2
Increasing the Batch Size of a QESD Crystallization by Using a MSMPR Crystallizer.使用MSMPR结晶器增加QESD结晶的批量大小。
Pharmaceutics. 2022 Jun 9;14(6):1227. doi: 10.3390/pharmaceutics14061227.
3
Towards a better understanding of the role of stabilizers in QESD crystallizations.
为了更好地理解稳定剂在QESD结晶过程中的作用。
Pharm Res. 2022 Dec;39(12):3123-3136. doi: 10.1007/s11095-022-03212-2. Epub 2022 Mar 9.